These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8532145)

  • 1. Behavioural and neurochemical effects of OPC-14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brain.
    Semba J; Watanabe A; Kito S; Toru M
    Neuropharmacology; 1995 Jul; 34(7):785-91. PubMed ID: 8532145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
    Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F
    Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
    Kikuchi T; Tottori K; Uwahodo Y; Hirose T; Miwa T; Oshiro Y; Morita S
    J Pharmacol Exp Ther; 1995 Jul; 274(1):329-36. PubMed ID: 7616416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.
    Der-Ghazarian T; Charntikov S; Varela FA; Crawford CA; McDougall SA
    J Neural Transm (Vienna); 2010 May; 117(5):573-83. PubMed ID: 20372943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function.
    Jordan S; Koprivica V; Dunn R; Tottori K; Kikuchi T; Altar CA
    Eur J Pharmacol; 2004 Jan; 483(1):45-53. PubMed ID: 14709325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z; Ichikawa J; Dai J; Meltzer HY
    Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.
    Etievant A; Bétry C; Arnt J; Haddjeri N
    Neurosci Lett; 2009 Aug; 460(1):82-6. PubMed ID: 19450663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland.
    Inoue T; Domae M; Yamada K; Furukawa T
    J Pharmacol Exp Ther; 1996 Apr; 277(1):137-43. PubMed ID: 8613910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial agonistic effects of OPC-14597, a potential antipsychotic agent, on yawning behavior in rats.
    Fujikawa M; Nagashima M; Inoue T; Yamada K; Furukawa T
    Pharmacol Biochem Behav; 1996 Apr; 53(4):903-9. PubMed ID: 8801596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats.
    Oshibuchi H; Inada K; Sugawara H; Ishigooka J
    Eur J Pharmacol; 2009 Aug; 615(1-3):83-90. PubMed ID: 19477171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats.
    Nordquist RE; Risterucci C; Moreau JL; von Kienlin M; Künnecke B; Maco M; Freichel C; Riemer C; Spooren W
    Neuropharmacology; 2008 Feb; 54(2):405-16. PubMed ID: 18054053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental area.
    Momiyama T; Amano T; Todo N; Sasa M
    Eur J Pharmacol; 1996 Aug; 310(1):1-8. PubMed ID: 8880060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour.
    Dahan L; Husum H; Mnie-Filali O; Arnt J; Hertel P; Haddjeri N
    J Psychopharmacol; 2009 Mar; 23(2):177-89. PubMed ID: 18515444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.
    Claustre Y; Peretti DD; Brun P; Gueudet C; Allouard N; Alonso R; Lourdelet J; Oblin A; Damoiseau G; Françon D; Suaud-Chagny MF; Steinberg R; Sevrin M; Schoemaker H; George P; Soubrié P; Scatton B
    Neuropsychopharmacology; 2003 Dec; 28(12):2064-76. PubMed ID: 12902994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives.
    Oshiro Y; Sato S; Kurahashi N; Tanaka T; Kikuchi T; Tottori K; Uwahodo Y; Nishi T
    J Med Chem; 1998 Feb; 41(5):658-67. PubMed ID: 9513593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
    Rugsley TA; Davis MD; Akunne HC; Cooke LW; Whetzel SZ; MacKenzie RG; Shih YH; van Leeuwen DH; DeMattos SB; Georgic LM
    J Pharmacol Exp Ther; 1995 Aug; 274(2):898-911. PubMed ID: 7636753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic effects of OPC-14597, a novel antipsychotic drug, on quinpirole- and (-)-sulpiride-induced changes in evoked dopamine release in rat striatal slices.
    Yamada S; Harano M; Yokoo H; Tanaka M
    J Pharm Pharmacol; 1997 Feb; 49(2):206-8. PubMed ID: 9055196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of presynaptic 5-HT
    Mombereau C; Arnt J; Mørk A
    Pharmacol Biochem Behav; 2017 Feb; 153():141-146. PubMed ID: 28057524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist.
    Pugsley TA; Christofferson CL; Corbin A; DeWald HA; Demattos S; Meltzer LT; Myers SL; Shih YH; Whetzel SZ; Wiley JN
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1147-58. PubMed ID: 1361570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.